咸亨國際(605056.SH):擬使用募集資金6695.91萬元向浙江創新產業提供無息借款並用於“研發中心建設項目”
格隆匯3月6日丨咸亨國際(605056.SH)公佈,公司於2022年3月4日在杭州市拱墅區興業街27號咸亨國際應急裝備中心召開了第二屆董事會第十五次會議,第二屆監事會第十次會議,審議通過了《關於使用募集資金向全資子公司提供借款用於實施募投項目的議案》,公司將“研發中心建設項目”對應的6695.91萬元人民幣以借款形式出借給全資子公司浙江咸亨創新產業中心有限公司(“浙江創新產業”),並開具專門賬户用於存放上述借款,以保證募集資金使用安全。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.